| Literature DB >> 21060671 |
Atsushi Miki1, Motohiro Shirakashi, Kiyoshi Yaoeda, Atsushi Fukushima, Mineo Takagi, Haruki Abe.
Abstract
PURPOSE: To evaluate the optic disc characteristics of eyes with superior segmental optic hypoplasia (SSOH) using the Heidelberg retina tomograph (HRT). PATIENTS AND METHODS: Thirteen eyes of 13 Japanese patients with SSOH were studied with the HRT (software version: 3.0). The group included six males and seven females, with a mean age of 34.7 years. Six optic disc parameters in the six sectors derived from the patients with SSOH were compared with those of 13 eyes of 13 normal controls. In addition, the diagnostic classification performance of the Frederick S Mikelberg (FSM) discriminant function, glaucoma probability score (GPS), and Moorfields regression analysis (MRA) were assessed.Entities:
Keywords: Heidelberg retina tomography; superior segmental optic hypoplasia
Year: 2010 PMID: 21060671 PMCID: PMC2964957 DOI: 10.2147/OPTH.S13864
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Demographic and clinical characteristics of the subjects included in the study
| SSOH (N = 13) | Normal (N = 13) | ||
|---|---|---|---|
| Sex (M/F) | 6/7 | 4/9 | 0.420 |
| Age (years) | 34.7 ± 12.9 (15,53) | 34.6 ± 9.1 (22,55) | 0.840 |
| Refraction (diopters) | −3.71 ± 3.31 (−10.00, −0.50) | −3.58 ± 1.92 (−7.25, −1.13) | 0.614 |
| MD (dB) | −4.35 ± 4.37 (−11.96, +1.76) | 1.26 ± 1.04 (−0.88, +2.92) | <0.001 |
Notes: Data are presented as mean ± standard deviation (range);
P value is for comparison between SSOH and normal eyes using Mann–Whitney’s U test;
mean deviation of Humphrey 30-2 visual field.
Abbreviations: SSOH, superior segmental optic hypoplasia; M, male; F, female; MD, mean deviation.
Global and segmental optic disc parameters and areas under the receiver operating characteristic curve for each parameter
| SSOH (N = 13) | Normal (N = 13) | AUC | ||
|---|---|---|---|---|
| DA global | 1.97 ± 0.55 (1.18–3.17) | 2.05 ± 0.47 (1.12–2.86) | 0.650 | 0.556 (0.350–0.749) |
| DA temporal | 0.48 ± 0.15 (0.24–0.81) | 0.47 ± 0.11 (0.25–0.63) | 0.920 | 0.515 (0.313–0.714) |
| DA TS | 0.26 ± 0.05 (0.19–0.36) | 0.29 ± 0.07 (0.18–0.43) | 0.243 | 0.636 (0.426–0.814) |
| DA TI | 0.25 ± 0.07 (0.15–0.40) | 0.28 ± 0.08 (0.15–0.45) | 0.287 | 0.624 (0.414–0.804) |
| DA nasal | 0.47 ± 0.15 (0.24–0.79) | 0.48 ± 0.12 (0.24–0.64) | 0.801 | 0.533 (0.328–0.729) |
| DA NS | 0.25 ± 0.08 (0.14–0.44) | 0.26 ± 0.07 (0.13–0.39) | 0.579 | 0.568 (0.361–0.759) |
| DA NI | 0.26 ± 0.06 (0.20–0.39) | 0.27 ± 0.06 (0.18–0.37) | 0.311 | 0.621 (0.411–0.802) |
| CA global | 0.93 ± 0.51 (0.29–1.98) | 0.40 ± 0.22 (0.03–0.78) | 0.007 | 0.805 (0.603–0.932) |
| CA temporal | 0.28 ± 0.16 (0.08–0.58) | 0.19 ± 0.10 (0.02–0.32) | 0.153 | 0.666 (0.455–0.837) |
| CA TS | 0.14 ± 0.06 (0.05–0.23) | 0.06 ± 0.04 (0.00–0.11) | < | 0.882 (0.694–0.973) |
| CA TI | 0.09 ± 0.07 (0.00–0.21) | 0.04 ± 0.03 (0.00–0.09) | 0.050 | 0.728 (0.519–0.882) |
| CA nasal | 0.21 ± 0.15 (0.00–0.54) | 0.06 ± 0.05 (0.00–0.16) | 0.003 | 0.831 (0.634–0.947) |
| CA NS | 0.15 ± 0.06 (0.02–0.28) | 0.04 ± 0.03 (0.00–0.11) | < | 0.932 (0.760–0.991) |
| CA NI | 0.07 ± 0.05 (0.00–0.15) | 0.02 ± 0.01 (0.00–0.04) | 0.002 | 0.843 (0.648–0.954) |
| RA global | 1.04 ± 0.18 (0.78–1.38) | 1.66 ± 0.45 (1.03–2.53) | < | 0.932 (0.760–0.991) |
| RA temporal | 0.20 ± 0.05 (0.09–0.30) | 0.28 ± 0.11 (0.18–0.52) | 0.019 | 0.769 (0.563–0.910) |
| RA TS | 0.12 ± 0.03 (0.07–0.18) | 0.23 ± 0.07 (0.11–0.33) | < | 0.926 (0.752–0.989) |
| RA TI | 0.16 ± 0.04 (0.09–0.25) | 0.24 ± 0.08 (0.14–0.43) | 0.002 | 0.843 (0.648–0.954) |
| RA nasal | 0.26 ± 0.08 (0.10–0.38) | 0.42 ± 0.11 (0.21–0.62) | < | 0.891 (0.706–0.977) |
| RA NS | 0.10 ± 0.03 (0.04–0.16) | 0.22 ± 0.07 (0.13–0.33) | < | 0.959 (0.799–0.994) |
| RA NI | 0.20 ± 0.05 (0.14–0.28) | 0.26 ± 0.06 (0.18–0.37) | 0.006 | 0.811 (0.610–0.935) |
| CDAR global | 0.45 ± 0.14 (0.23–0.66) | 0.19 ± 0.10 (0.01–0.35) | < | 0.926 (0.752–0.989) |
| CDAR temporal | 0.55 ± 0.19 (0.24–0.82) | 0.40 ± 0.18 (0.06–0.63) | 0.072 | 0.710 (0.500–0.869) |
| CDAR TS | 0.52 ± 0.15 (0.24–0.78) | 0.21 ± 0.15 (0.01–0.47) | < | 0.929 (0.756–0.990) |
| CDAR TI | 0.32 ± 0.21 (0.01–0.67) | 0.14 ± 0.11 (0.00–0.27) | 0.026 | 0.754 (0.547–0.900) |
| CDAR nasal | 0.41 ± 0.22 (0.00–0.68) | 0.12 ± 0.10 (0.00–0.32) | 0.861 (0.669–0.963) | |
| CDAR NS | 0.58 ± 0.14 (0.17–0.74) | 0.15 ± 0.12 (0.00–0.43) | < | 0.970 (0.817–0.992) |
| CDAR NI | 0.24 ± 0.15 (0.00–0.48) | 0.06 ± 0.06 (0.00–0.16) | 0.855 (0.662–0.960) | |
| HVC | 0.39 ± 0.13 (0.18–0.68) | 0.41 ± 0.07 (0.27–0.52) | 0.264 | 0.633 (0.423–0.811) |
| HVC temporal | 0.15 ± 0.06 (0.04–0.25) | 0.20 ± 0.06 (0.12–0.34) | 0.101 | 0.692 (0.482–0.856) |
| HVC TS | 0.16 ± 0.15 (0.02–0.48) | 0.17 ± 0.06 (0.05–0.29) | 0.186 | 0.654 (0.443–0.828) |
| HVC TI | 0.21 ± 0.08 (0.10–0.38) | 0.23 ± 0.09 (0.09–0.38) | 0.579 | 0.568 (0.361–0.759) |
| HVC nasal | 0.14 ± 0.07 (0.06–0.27) | 0.11 ± 0.04 (0.06–0.23) | 0.479 | 0.586 (0.378–0.774) |
| HVC NS | 0.09 ± 0.04 (0.03–0.18) | 0.05 ± 0.02 (0.03–0.11) | 0.019 | 0.769 (0.563–0.910) |
| HVC NI | 0.09 ± 0.05 (0.02–0.24) | 0.07 ± 0.04 (0.02–0.15) | 0.186 | 0.654 (0.443–0.828) |
| CSM | −0.08 ± 0.10 (−0.28–0.11) | −0.21 ± 0.05 (−0.28, −0.10) | < | 0.882 (0.694–0.973) |
| CSM temporal | −0.07 ± 0.08 (−0.19–0.09) | −0.11 ± 0.06 (−0.22, −0.01) | 0.113 | 0.686 (0.476–0.852) |
| CSM TS | 0.05 ± 0.09 (−0.08–0.25) | −0.14 ± 0.12 (−0.31–0.03) | < | 0.905 (0.725–0.983) |
| CSM TI | −0.07 ± 0.14 (−0.37–0.16) | −0.22 ± 0.10 (−0.39, −0.07) | 0.006 | 0.811 (0.610–0.935) |
| CSM nasal | −0.00 ± 0.15 (−0.25–0.30) | −0.18 ± 0.13 (−0.46, −0.02) | 0.005 | 0.814 (0.613–0.937) |
| CSM NS | 0.15 ± 0.15 (−0.13–0.40) | −0.18 ± 0.08 (−0.33, −0.03) | < | 0.988 (0.845–1.000) |
| CSM NI | −0.10 ± 0.18 (−0.40–0.18) | −0.31 ± 0.15 (−0.55, –0.04) | 0.006 | 0.808 (0.606–0.934) |
Notes: Data are presented as mean ± standard deviation (range);
P value is for comparison of the parameters between SSOH and normal eyes using Mann–Whitney’s U test. Because of the multiple comparisons, the Bonferroni correction was applied, with a level of significance of 0.00119. Bold P values are statistically significant.
Data are expressed with 95% confidence intervals of each value in parentheses.
Abbreviations: DA, disc area; CA, cup area; RA, rim area; CDAR, cup-to-disc area ratio; HVC, height variation contour; CSM, cup shape measure; TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior.
Figure 1A receiver operating characteristic curve for the nasal superior cup shape measure.
ROC, sensitivity, and specificity for the FSM discriminant function, MRA, and GPS used to discriminate between normal eyes and eyes with SSOH
| ROC | Sensitivity | Specificity | ||
|---|---|---|---|---|
| FSM | 0.976 (0.826–0.990) | 92.3 (63.9–98.7)% | 92.3 (63.9–98.7)% | |
| MRA overall | 0.914 (0.736–0.986) | BL = abnormal | 84.6 (54.5–97.6)% | 92.3 (63.9–98.7)% |
| BL = normal | 76.9 (46.2–94.7)% | 100 (75.1–100)% | ||
| MRA global | 0.885 (0.698–0.974) | BL = abnormal | 76.9 (46.2–94.7)% | 100 (75.1–100)% |
| BL = normal | 76.9 (46.2–94.7)% | 100 (75.1–100)% | ||
| MRA temporal | 0.538 (0.334–0.734) | BL = abnormal | 7.7 (1.3–36.1)% | 100 (75.1–100)% |
| BL = normal | 0.0 (0.0–24.9)% | 100 (75.1–100)% | ||
| MRA temporal superior | 0.654 (0.443–0.828) | BL = abnormal | 30.8 (9.3–61.4)% | 100 (75.1–100)% |
| BL = normal | 30.8 (9.3–61.4)% | 100 (75.1–100)% | ||
| MRA temporal inferior | 0.615 (0.406–0.797) | BL = abnormal | 23.1 (5.3–53.8)% | 100 (75.1–100)% |
| BL = normal | 23.1 (5.3–53.8)% | 100 (75.1–100)% | ||
| MRA nasal | 0.846 (0.651–0.955) | BL = abnormal | 69.2 (38.6–90.7)% | 100 (75.1–100)% |
| BL = normal | 69.2 (38.6–90.7)% | 100 (75.1–100)% | ||
| MRA nasal superior | 0.956 (0.794–0.994) | BL = abnormal | 92.3 (63.9–98.7)% | 92.3 (63.9–98.7)% |
| BL = normal | 84.6 (54.5–97.6)% | 100 (75.1–100)% | ||
| MRA nasal inferior | 0.654 (0.443–0.828) | BL = abnormal | 30.8 (9.3–61.4)% | 100 (75.1–100)% |
| BL = normal | 30.8 (9.3–61.4)% | 100 (75.1–100)% | ||
| GPS overall | 0.710 (0.500–0.869) | BL = abnormal | 46.2 (19.3–74.8)% | 92.3 (63.9–98.7)% |
| BL = normal | 46.2 (19.3–74.8)% | 100 (75.1–100)% | ||
| GPS global | 0.731 (0.522–0.884) | BL = abnormal | 46.2 (19.3–74.8)% | 100 (75.1–100)% |
| BL = normal | 46.2 (19.3–74.8)% | 100 (75.1–100)% | ||
| GPS temporal | 0.727 (0.509–0.886) | BL = abnormal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% | ||
| GPS temporal superior | 0.706 (0.48–0.872) | BL = abnormal | 45.5 (16.9–76.5)% | 92.3 (63.9–98.7)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% | ||
| GPS temporal inferior | 0.727 (0.509–0.886) | BL = abnormal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% | ||
| GPS nasal | 0.727 (0.509–0.886) | BL = abnormal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% | ||
| GPS nasal superior | 0.727 (0.509–0.886) | BL = abnormal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% | ||
| GPS nasal inferior | 0.727 (0.509–0.886) | BL = abnormal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
| BL = normal | 45.5 (16.9–76.5)% | 100 (75.1–100)% |
Note: Data are expressed with 95% confidence intervals of each value in the parentheses.
Abbreviations: FSM, FSM classification; MRA, Moorfield regression analysis; GPS, glaucoma probability score; “BL = abnormal”, when the borderline is regarded as abnormal; “BL = normal”, when the borderline is regarded as normal; ROC, receiver operating characteristic; SSOH; superior segmental optic hypoplasia.
Figure 2A receiver operating characteristic curve for the nasal superior Moorfields regression analysis (MRA).